CLABSIs aren't just for inpatients: the need to identify CLABSI burden among outpatients
Research Publication Date:
09/12/2024
Research Locations:
Research Topics:
Research Citation:
Oladapo-Shittu O, Cosgrove SE, Rock C, Hsu YJ, Klein E, Harris AD, Mejia Chew C, Saunders H, Ching PR, Gadala A, Mayoryk S, Pineles L, Maragakis LL, Salinas AB, Helsel T, Keller SC; Centers for Disease Control and Prevention’s Prevention Epicenters Program. CLABSIs aren't just for inpatients: the need to identify CLABSI burden among outpatients. Antimicrob Steward Healthc Epidemiol. 2024 Sep 12;4(1):e132. doi: 10.1017/ash.2024.384. PMID: 39290627; PMCID: PMC11406563.
Research Abstract
CLABSIs in the community may be underrecognized and may cause significant morbidity and mortality. Acute care hospital infection preventionists have the expertise to collaborate with community providers to identify and prevent co-CLABSI but may themselves require additional support to share this expertise. Mandatory reporting measures and resulting reimbursement models would prompt more organizations to collaborate on co-CLABSI prevention. An increased regulatory emphasis on healthcare-associated infection (HAI) prevention at care transitions could help with starting to build the infrastructure around co-CLABSI reporting. However, to understand the burden of disease, it is important to understand the number and rates of co-CLABSI. State health departments should develop ways to track health devices to better understand the number of devices in the community, such as through a dashboard or health information exchange tool, and work closely with other community-based health providers to provide feedback to community-based health providers about complications and rates. Additional resources and infrastructure would be needed to assist with education and devoted time for surveillance.